Pinpoint secures new investment to develop "ground-breaking" products
The financial backing will help the company to develop a new generation of microbial air monitors that enables continuous monitoring as demanded by the Annex 1 revision.
Pinpoint Scientific, specialist product designers and manufacturers of environmental monitoring solutions for the pharmaceutical and related industries, has secured further investment into the business, to aid the development of its ImpactAir range of environmental monitoring solutions.
Cherwell Laboratories and Development Bank of Wales (DBW) have both invested in Pinpoint and taken a minority share in the business. The investment not only secures jobs in South Wales, a key objective of DBW, but also allows the business to bring to the market some exciting new products within the ImpactAir range. Cherwell is an existing distributor of ImpactAir products within the UK and Andy Whittard, Cherwell’s Managing Director, has also taken a seat on the Pinpoint board to help with business strategy and planning.
Gethin Jones, Managing Director of Pinpoint and the designer of the ImpactAir product said: “This is an exciting time for Pinpoint. We have been working on very innovative ideas to develop a new generation of microbial air monitors to meet the new pharmaceutical regulations. This investment is perfect timing for Pinpoint and allows us to create a range of ground-breaking products for this market.”
Andy Whittard added: “I am really excited to join up with Gethin and the team at Pinpoint to help create an exciting range of products for pharma EM. The Annex 1 revision is potentially going to shift the dynamics for EM within grade A spaces and I think Pinpoint is well placed to service that need with innovative and highly effective monitoring devices.”
Sarah Smith, Investment Executive with the Technology Venture Investment team at the DBM said: “Our Wales Technology Seed Fund provides businesses like Pinpoint with the funding that they need to further develop their products. Together with Cherwell Laboratories, we will work with the team to support their growth in this niche sector as providers of continuous air quality for life science cleanrooms. This is an exciting time for the team as they look to capitalise on their existing customer base and scale the business. We wish them every success.”
The ImpactAir range of microbial air samplers is shortly to be expanded with the introduction of the new ImpactAir ISO-90 Monitoring Platform. ImpactAir is designed for continuous monitoring in high-grade areas, where in-process sampling of viable particles is often critical. The ImpactAir ISO is a modular system designed to integrate into isolators or RABS, using an external controller and local or remotely located air mover. It can be designed in almost any orientation using standard or custom-made connections. The ISO-90-Monitoring Head features a chamber for 90-mm agar plates and a highly efficient slit to agar sampling method. The low D50 value and ability to sample for long periods makes the ISO-90 ideal for continuous monitoring as demanded by the Annex 1 revision.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance